ARTÍCULOS
Pandey et al. Alzheimer's Research & Therapy (2025) 17:1
Plasma phospho-tau217 as a predictive
biomarker for Alzheimer’s disease in a large
south American cohort
Neetesh Pandey1, Zikun Yang1, Basilio Cieza1, Dolly Reyes-Dumeyer1,2,3, Min Suk Kang1,2,3, Rosa Montesinos4
,
Marcio Soto-Añari5,6, Nilton Custodio4, Lawrence S. Honig1,2,3 and Giuseppe Tosto1,2,3,7*
Accepted November 14, 2024 Published January 2, 2025
JCO Global Oncol 11:e2400431 © 2025 by American Society of Clinical Oncology
Treatment Patterns for Metastatic Urothelial Carcinoma
Across Eight Mexican Centers: The ALEBRIJE Study
Evelyn Lilian Beas-Lozano, MD1; Yuly A. Remolina-Bonilla, MD1 ; Rosa Caballero, MD1 ; Nora Sobrevilla-Moreno, MD2 ;
Perla Perez-Perez, MD3; Maria Guadalupe D ́ıaz-Alvarado, MD3; Omar Alejandro Zayas-Villanueva, MD4 ; Erika Adriana Martinez-Castañeda, MD5; Saul Campos-Gomez, MD6 ; Luis Arturo Cardoso-Aparicio, MD7 ; Dolores Mendoza-Oliva, MD8; and Maria T. Bourlon, MD, MSc, FASCO1
Received: 26 May 2024
Accepted: 27 July 2024
Accepted corrected: 23 August 2024
Published: 30 January 2025
Ginkgolide B alleviates Parkinson's disease in rats by resisting
oxidative stress and inflammatory response and activating
PI3K/Akt signaling pathway
[Ginkgólido B alivia la enfermedad de Parkinson en ratas mediante la resistencia al estrés oxidativo y la
respuesta inflamatoria y la activación de la vía de señalización PI3K/Akt]
Chensong Deng1,
*, Qi Yang2,
* & Wenju Gu1
1Department of Neurology & 2Department of Medical Services
Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China
*Contributed equally